226 related articles for article (PubMed ID: 32859062)
1. The Effect of Resveratrol or Curcumin on Head and Neck Cancer Cells Sensitivity to the Cytotoxic Effects of Cisplatin.
Bostan M; Petrică-Matei GG; Radu N; Hainarosie R; Stefanescu CD; Diaconu CC; Roman V
Nutrients; 2020 Aug; 12(9):. PubMed ID: 32859062
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol Modulation of Apoptosis and Cell Cycle Response to Cisplatin in Head and Neck Cancer Cell Lines.
Bostan M; Mihaila M; Petrica-Matei GG; Radu N; Hainarosie R; Stefanescu CD; Roman V; Diaconu CC
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204834
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin effect on head and neck squamous cell carcinoma cells is modulated by ERK1/2 protein kinases.
Bostan M; Petrică-Matei GG; Ion G; Radu N; Mihăilă M; Hainăroşie R; Braşoveanu LI; Roman V; Constantin C; Neagu MT
Exp Ther Med; 2019 Dec; 18(6):5041-5051. PubMed ID: 31798724
[TBL] [Abstract][Full Text] [Related]
4. Combinatorial Effects of Curcumin with an Anti-Neoplastic Agent on Head and Neck Squamous Cell Carcinoma Through the Regulation of EGFR-ERK1/2 and Apoptotic Signaling Pathways.
Sivanantham B; Sethuraman S; Krishnan UM
ACS Comb Sci; 2016 Jan; 18(1):22-35. PubMed ID: 26505786
[TBL] [Abstract][Full Text] [Related]
5. A novel curcumin analog (H-4073) enhances the therapeutic efficacy of cisplatin treatment in head and neck cancer.
Kumar B; Yadav A; Hideg K; Kuppusamy P; Teknos TN; Kumar P
PLoS One; 2014; 9(3):e93208. PubMed ID: 24675768
[TBL] [Abstract][Full Text] [Related]
6. Cell-cycle inhibition and apoptosis induced by curcumin and cisplatin or oxaliplatin in human ovarian carcinoma cells.
Montopoli M; Ragazzi E; Froldi G; Caparrotta L
Cell Prolif; 2009 Apr; 42(2):195-206. PubMed ID: 19236381
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia, but Not Normoxia, Reduces Effects of Resveratrol on Cisplatin Treatment in A2780 Ovarian Cancer Cells: A Challenge for Resveratrol Use in Anticancer Adjuvant Cisplatin Therapy.
Synowiec A; Brodaczewska K; Wcisło G; Majewska A; Borkowska A; Filipiak-Duliban A; Gawrylak A; Wilkus K; Piwocka K; Kominek A; Waś H; Lewicki S; Siewiera J; Szczylik C; Szenajch J; Kubiak JZ; Kieda C
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982788
[TBL] [Abstract][Full Text] [Related]
8. Milk-Derived Exosomes as Nanocarriers to Deliver Curcumin and Resveratrol in Breast Tissue and Enhance Their Anticancer Activity.
González-Sarrías A; Iglesias-Aguirre CE; Cortés-Martín A; Vallejo F; Cattivelli A; Del Pozo-Acebo L; Del Saz A; López de Las Hazas MC; Dávalos A; Espín JC
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270004
[TBL] [Abstract][Full Text] [Related]
9. Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells.
Basak SK; Zinabadi A; Wu AW; Venkatesan N; Duarte VM; Kang JJ; Dalgard CL; Srivastava M; Sarkar FH; Wang MB; Srivatsan ES
Oncotarget; 2015 Jul; 6(21):18504-17. PubMed ID: 26098778
[TBL] [Abstract][Full Text] [Related]
10. Pro-apoptotic genes as new targets for single and combinatorial treatments with resveratrol and curcumin in colorectal cancer.
Gavrilas LI; Cruceriu D; Ionescu C; Miere D; Balacescu O
Food Funct; 2019 Jun; 10(6):3717-3726. PubMed ID: 31169275
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro effects of curcumin on head and neck carcinoma: a systematic review.
Borges GÁ; Rêgo DF; Assad DX; Coletta RD; De Luca Canto G; Guerra EN
J Oral Pathol Med; 2017 Jan; 46(1):3-20. PubMed ID: 27219631
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol‑induced REG III expression enhances chemo‑ and radiosensitivity in head and neck cancer in xenograft mice.
Mikami S; Ota I; Masui T; Uchiyama T; Okamoto H; Kimura T; Takasawa S; Kitahara T
Oncol Rep; 2019 Jul; 42(1):436-442. PubMed ID: 31059079
[TBL] [Abstract][Full Text] [Related]
13. Synthetic resveratrol-curcumin hybrid derivative inhibits mitosis progression in estrogen positive MCF-7 breast cancer cells.
de Freitas Silva M; Coelho LF; Guirelli IM; Pereira RM; Ferreira-Silva GÁ; Graravelli GY; Horvath RO; Caixeta ES; Ionta M; Viegas C
Toxicol In Vitro; 2018 Aug; 50():75-85. PubMed ID: 29501629
[TBL] [Abstract][Full Text] [Related]
14. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
[TBL] [Abstract][Full Text] [Related]
15. New Hybrids Based on Curcumin and Resveratrol: Synthesis, Cytotoxicity and Antiproliferative Activity against Colorectal Cancer Cells.
Hernández C; Moreno G; Herrera-R A; Cardona-G W
Molecules; 2021 May; 26(9):. PubMed ID: 34062841
[TBL] [Abstract][Full Text] [Related]
16. Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma.
Liontas A; Yeger H
Anticancer Res; 2004; 24(2B):987-98. PubMed ID: 15161054
[TBL] [Abstract][Full Text] [Related]
17. Targeting acid ceramidase sensitises head and neck cancer to cisplatin.
Roh JL; Park JY; Kim EH; Jang HJ
Eur J Cancer; 2016 Jan; 52():163-72. PubMed ID: 26687835
[TBL] [Abstract][Full Text] [Related]
18. Molecular targets for anticancer redox chemotherapy and cisplatin-induced ototoxicity: the role of curcumin on pSTAT3 and Nrf-2 signalling.
Fetoni AR; Paciello F; Mezzogori D; Rolesi R; Eramo SL; Paludetti G; Troiani D
Br J Cancer; 2015 Nov; 113(10):1434-44. PubMed ID: 26469832
[TBL] [Abstract][Full Text] [Related]
19. EF24 and RAD001 potentiates the anticancer effect of platinum-based agents in human malignant pleural mesothelioma (MSTO-211H) cells and protects nonmalignant mesothelial (MET-5A) cells.
Onen HI; Yilmaz A; Alp E; Celik A; Demiroz SM; Konac E; Kurul IC; Menevse ES
Hum Exp Toxicol; 2015 Feb; 34(2):117-26. PubMed ID: 25028262
[TBL] [Abstract][Full Text] [Related]
20. Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells.
Herůdková J; Paruch K; Khirsariya P; Souček K; Krkoška M; Vondálová Blanářová O; Sova P; Kozubík A; Hyršlová Vaculová A
Neoplasia; 2017 Oct; 19(10):830-841. PubMed ID: 28888100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
